Amneal Pharmaceuticals
Manufacturing · New Jersey, United States · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
400 Crossing Blvd Fl 3, Bridgewater, New...Phone Number
(908) 947-3120Website
www.amneal.comRevenue
$3 BillionStock Symbol
AMRXIndustry
About Amneal Pharmaceuticals
Amneal Pharmaceuticals Org Chart
Is Amneal Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Amneal Pharmaceuticals had a recent Job posting/layoffs
Check if Amneal Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Check out if Amneal Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Amneal Pharmaceuticals
Product Launch: Get notified when Amneal Pharmaceuticals launches new products
Amneal Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Amneal Pharmaceuticals has new funding data
Earning: See what the market has to say on Amneal Pharmaceuticals recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Amneal Pharmaceuticals
Compare insights from companies similar to Amneal Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Amneal Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Amneal Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Amneal Pharmaceuticals.
Amneal Pharmaceuticals financials insights
Gather financial insights about Amneal Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$250M
Amneal Pharmaceuticals Tech Stack
A closer look at the technologies used by Amneal Pharmaceuticals
Most Recent Scoops
Amneal Pharmaceuticals News & Media
Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations
MILAN and BRIDGEWATER, N.J., June 29, 2026 (GLOBE NEWSWIRE) -- Zambon and Amneal Pharmaceuticals today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European Medicines Agency (EMA) for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized witAmneal Pharmaceuticals (AMRX) Is Up 17.8% After CREXONT Phase 4 Gains And New Oncology Launch
Earlier this month, Amneal Pharmaceuticals reported positive interim Phase 4 ELEVATE-PD results showing that CREXONT extended-release carbidopa/levodopa capsules improved “Good On” time, reduced “Off” time, and enhanced motor scores in Parkinson’s patients across multiple prior treatment regimens, while maintaining a safety profile consistent with earlier trials and its FDA label. In parallel, Amneal secured FDA approval and 180 days of Competitive Generic Therapy exclusivity for a...Dispensary of Hope Launches "Hope Alliance" Campaign with Support from Amneal Pharmaceuticals
Amneal's Commitment Helps Support a Reliable Supply of Essential Medicines for Uninsured and Underserved Patients Nationwide NASHVILLE, Tenn., June 10, 2026 /PRNewswire/ -- Dispensary of Hope announced the launch of its national "Hope Alliance" campaign this year, a strategic initiative...Amneal Pharmaceuticals Bets on Biosimilars, Patches to Power Next Growth Phase
Amneal Pharmaceuticals (NASDAQ:AMRX) Co-Founder, President and Co-Chief Executive Officer Chirag Patel said the company is entering a stronger growth phase, driven by momentum in its existing generics portfolio, a newly expanded biosimilars platform and specialty product launches. Speaking at a Gol
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Amneal Pharmaceuticals
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a fully integrated global essential medicines company powered by a robust U.S. generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets. Together, were rapidly becoming one of the most dynamic, purpose-dr... Read More
